CLINICAL STUDY SHOWS DETECTION OF CTCS IN GLIOBLASTOMA PATIENTS GBM CTC isolation only possible with Parsortix label-free methodology Data presented at the 7th ACTC meeting ANGLE plc (AIM:AGL ...
CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma Patients GBM CTC isolation only possible with Parsortix label-free ...
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking ...
The various roles for oncology nurses in the conduct of clinical trials were described in a presentation at the 2025 ONS Bridge virtual meeting.
Neuralink's CEO said this type of device will eventually enable people to interact with large language models (LLMs) without ...
The 2025 ASTRO annual meeting featured a prostate cancer session and a presentation by Dr. Angela Jia discussing the clinical ...
Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, ...
It is important to empower patients to receive immunizations and address concerns amid changes to the CDC’s advisory ...
Genmab acquires Merus for $8bn, adding promising oncology asset petosemtamab. Check out my thoughts on this deal and my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback